Pre ‐treatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP)
ConclusionsInitiating methylprednisolone at a conventional dose provided no significant benefit compared to giving oral prednisone only to adults with ITP.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Ana ïs Essilini, Thibault Comont, Johanne Germain, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Sailler, Maryse Lapeyre‐Mestre, Odile Beyne‐rauzy, Bertrand Godeau, Daniel Adoue, Guillaume Moulis, Tags: Original Article Source Type: research
More News: Corticosteroid Therapy | Drugs & Pharmacology | Hematology | Methylprednisolone | Prednisone | Thrombocytopenia